AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 182 filers reported holding AMAG PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 6.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $28,000 | +27.3% | 2,157 | -32.6% | 0.00% | – |
Q2 2020 | $22,000 | +633.3% | 3,200 | +649.4% | 0.00% | – |
Q1 2020 | $3,000 | -94.9% | 427 | -91.2% | 0.00% | – |
Q4 2019 | $59,000 | +25.5% | 4,861 | +20.1% | 0.00% | – |
Q3 2019 | $47,000 | +46.9% | 4,046 | +26.1% | 0.00% | – |
Q2 2019 | $32,000 | +146.2% | 3,209 | +211.9% | 0.00% | – |
Q1 2019 | $13,000 | -69.8% | 1,029 | -64.1% | 0.00% | – |
Q4 2018 | $43,000 | -28.3% | 2,870 | -4.7% | 0.00% | – |
Q3 2018 | $60,000 | +1.7% | 3,013 | -0.2% | 0.00% | – |
Q2 2018 | $59,000 | +7.3% | 3,020 | +8.8% | 0.00% | – |
Q1 2018 | $55,000 | +19.6% | 2,776 | -18.4% | 0.00% | – |
Q4 2017 | $46,000 | -98.3% | 3,404 | -97.6% | 0.00% | -100.0% |
Q3 2017 | $2,635,000 | +23.4% | 142,788 | +23.0% | 0.00% | 0.0% |
Q2 2017 | $2,135,000 | +42.3% | 116,052 | +74.5% | 0.00% | +100.0% |
Q1 2017 | $1,500,000 | +2730.2% | 66,492 | +4071.4% | 0.00% | – |
Q4 2016 | $53,000 | -95.8% | 1,594 | -96.9% | 0.00% | -100.0% |
Q3 2016 | $1,270,000 | -10.7% | 51,808 | -12.8% | 0.00% | -50.0% |
Q2 2016 | $1,422,000 | -11.3% | 59,434 | -13.3% | 0.00% | 0.0% |
Q1 2016 | $1,604,000 | -29.9% | 68,568 | -9.5% | 0.00% | -33.3% |
Q4 2015 | $2,287,000 | +2099.0% | 75,781 | +2782.5% | 0.00% | – |
Q3 2015 | $104,000 | +1.0% | 2,629 | +76.2% | 0.00% | – |
Q2 2015 | $103,000 | -99.5% | 1,492 | -99.6% | 0.00% | -100.0% |
Q1 2015 | $22,885,000 | -42.4% | 418,664 | -55.1% | 0.03% | -40.0% |
Q4 2014 | $39,747,000 | +6.2% | 932,591 | -20.5% | 0.04% | +7.1% |
Q3 2014 | $37,421,000 | -9.7% | 1,172,691 | -41.4% | 0.04% | -8.7% |
Q2 2014 | $41,433,000 | +25.3% | 1,999,631 | +17.0% | 0.05% | +7.0% |
Q1 2014 | $33,067,000 | +10430.9% | 1,708,929 | +13114.7% | 0.04% | – |
Q4 2013 | $314,000 | +20.3% | 12,932 | +6.2% | 0.00% | – |
Q3 2013 | $261,000 | -3.7% | 12,173 | 0.0% | 0.00% | – |
Q2 2013 | $271,000 | – | 12,173 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HealthInvest Partners AB | 740,585 | $17,330,000 | 8.11% |
Palo Alto Investors LP | 2,906,194 | $68,005,000 | 5.28% |
Opaleye Management Inc. | 220,000 | $5,148,000 | 3.21% |
Endurant Capital Management LP | 265,180 | $6,205,000 | 2.01% |
FALCON POINT CAPITAL, LLC | 381,081 | $8,917,000 | 1.54% |
STELLIAM INVESTMENT MANAGEMENT, LP | 1,470,000 | $34,398,000 | 1.06% |
AlphaOne Investment Services, LLC | 91,824 | $2,149,000 | 0.88% |
ASHFORD CAPITAL MANAGEMENT INC | 153,325 | $3,588,000 | 0.85% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 55,097 | $1,289,000 | 0.84% |
Camber Capital Management LP | 600,000 | $14,040,000 | 0.82% |